Molecules 2018, 23, 381
7 of 9
The prebiotics and FOSs purified from the HSCCC separation were analyzed by HPLC-ELSD
◦
with a Xamide 100A column (250
consisted of acetonitrile–water (75:25, v/v) at a flow rate of 1.0 mL/min.
×
4.6 mm, id) and a column temperature of 25 C. The mobile phase
3
.6. Structural Identification
The identification of target compounds was carried out by ESI-MS on an Agilent 1100/MSD
1
13
and by H-NMR, C-NMR spectra on a Varian-600 NMR spectrometer with D O solvent and
2
1
13
tetramethylsilane (TMS) as internal standard. Comparing the ESI-MS, H-NMR, and C-NMR
data with the literature, the compounds I–III were identified as 1-kestose, 1,1-kestotetraose,
and 1,1,1-kestopentaose, respectively.
+
1
Compound kestose: ESI-MS m/z: 527 [M + Na] . H-NMR (D O, 600 MHz) δ: 5.26 (1H, d, J = 3.6 Hz,
2
G-1), 3.38 (1H, dd, J = 4.2, 9.6 Hz, G-2), 3.67 (1H, m, G-3), 3.30 (1H, t, J = 9.0 Hz, G-4), 3.58 (1H, m,
G-5), 3.64 (2H, m, G-6), 3.67 (1H, m, Fa-1), 3.57 (1H, m, Fa-1), 4.11 (1H, d, J = 9.0 Hz, Fa-3), 3.87 (1H, t,
J = 8.4 Hz, Fa-4), 3.71 (1H, m, Fa-5), 3.56 (1H, m, Fb-1), 3.50 (1H, m, Fb-1), 4.02 (1H, d, J = 8.4 Hz, Fb-3),
3
.91 (1H, t, J = 8.4 Hz, Fb-4), 3.70 (1H, m, Fb-5), 3.68 (1H, m, Fb-6), 3.52 (1H, m, Fb-6). 13C-NMR (D O,
2
150 MHz)
δ
: 92.4 (G-1), 71.0 (G-2), 72.3 (G-3), 69.1 (G-4), 72.4 (G-5), 60.0 (G-6), 60.2 (Fa-1), 103.6 (Fa-2),
76.5 (Fa-3), 73.7 (Fa-4), 81.0 (Fa-5), 62.0 (Fa-6), 60.7 (Fb-1), 103.1 (Fb-2), 76.5 (Fb-3), 74.3 (Fb-4), 81.1
(Fb-5), 62.2 (Fb-6). Compared with the data given in reference [25], peak I was identified as kestose.
+
1
Compound 1,1-kestotetraose: ESI-MS m/z: 689 [M + Na] . H-NMR (D O, 600 MHz)
δ: 5.25 (1H, d,
2
J = 3.6 Hz, G-1), 3.35 (1H, dd, J = 4.2, 9.6 Hz, G-2), 3.57 (1H, m, G-3), 3.29 (1H, t, J = 9.6 Hz, G-4),
3
3
.64 (1H, m, G-5), 3.63 (2H, m, G-6), 3.66 (1H, m, Fa-1), 3.57 (1H, m, Fa-1), 4.10 (1H, d, J = 9.0 Hz, Fa-3),
.87 (1H, t, J = 8.4 Hz, Fa-4), 3.69 (1H, m, Fa-5), 3.63 (1H, m, Fa-6), 3.61 (1H, m, Fa-6), 3.65 (1H, m,
Fb-1), 3.55 (1H, m, Fb-1), 4.05 (1H, d, J = 8.4 Hz, Fb-3), 3.90 (1H, t, J = 8.4 Hz, Fb-4), 3.68 (1H, m, Fb-5),
3
3
.64 (1H, m, Fb-6), 3.57 (1H, m, Fb-6), 3.57 (1H, m, Fc-1), 3.50 (1H, m, Fc-2), 4.01 (1H, d, J = 8.4 Hz, Fc-3),
13
.93 (1H, t, J = 8.4 Hz, Fc-4), 3.68 (1H, m, Fc-5), 3.65 (1H, m, Fc-6), 3.57 (1H, m, Fc-6). C-NMR (D O,
2
150 MHz)
δ
: 92.4 (G-1), 71.0 (G-2), 72.4 (G-3), 69.1 (G-4), 72.3 (G-5), 60.0 (G-6), 60.9 (Fa-1), 103.1 (Fa-2),
76.6 (Fa-3), 73.7 (Fa-4), 81.0 (Fa-5), 62.1 (Fa-6), 60.7 (Fb-1), 102.9 (Fb-2), 76.6 (Fb-3), 74.2 (Fb-4), 81.0
(
Fb-5), 62.1 (Fb-6), 60.2 (Fc-1), 103.6 (Fc-2), 77.3 (Fc-3), 74.3 (Fc-4), 81.1 (Fc-5), 62.1 (Fc-6). Compared with
the data given in reference [26], peak II was identified as 1,1-kestotetraose.
+
1
Compound 1,1,1-kestopentaose: ESI-MS m/z: 851 [M + Na] . H NMR (D O, 600 MHz)
δ: 5.26 (1H, d,
2
J = 4.2 Hz, G-1), 3.37 (1H, dd, J = 4.2, 9.6 Hz, G-2), 3.58 (1H, m, G-3), 3.30 (1H, t, J = 9.0 Hz, G-4), 3.67
(
(
1H, m, G-5), 3.62 (2H, m, G-6), 3.56 (1H, m, Fa-1), 3.65 (1H, m, Fa-1), 4.10 (1H, d, J = 8.4 Hz, Fa-3), 3.86
1H, t, J = 9.0 Hz, Fa-4), 3.57 (1H, m, Fa-5), 3.54 (2H, m, Fa-6), 3.65 (1H, m, Fb-1), 3.71 (1H, m, Fb-1),
4
(
.07 (1H, d, J = 8.4 Hz, Fb-3), 3.91 (1H, t, J = 8.4 Hz, Fb-4), 3.58 (1H, m, Fb-5), 3.55 (2H, m, Fb-6), 3.55
1H, m, Fc-1), 3.70 (1H, m, Fc-1), 4.05 (1H, d, J = 8.4 Hz, Fc-3), 3.94 (1H, t, J = 8.4 Hz, Fc-4), 3.58 (1H, m,
Fc-5), 3.55 (2H, m, Fc-6), 3.49 (1H, m, Fd-1), 3.58 (1H, m, Fd-1), 4.01 (1H, d, J = 8.4 Hz, Fd-3), 3.94 (1H, t,
J = 8.4 Hz, Fd-4), 3.58 (1H, m, Fd-5), 3.56 (2H, m, Fd-6). 13C NMR (D O, 150 MHz)
: 92.3 (G-1), 71.0
G-2), 72.3 (G-3), 69.1 (G-4), 72.4 (G-5), 60.0 (G-6), 60.3 (Fa-1), 103.5 (Fa-2), 76.5 (Fa-3), 73.7 (Fa-4), 81.0
Fa-5), 62.1 (Fa-6), 60.5 (Fb-1), 103.1 (Fb-2), 76.5 (Fb-3), 74.1 (Fb-4), 81.0 (Fb-5), 62.1 (Fb-6), 60.8 (Fc-1),
02.9 (Fc-2), 77.2 (Fc-3), 74.2 (Fc-4), 81.0 (Fc-5), 62.1 (Fc-6), 60.8 (Fd-1), 102.9 (Fd-2), 77.4 (Fd-3), 74.3
Fd-4), 81.1 (Fd-5), 62.1 (Fd-6). Compared with the data given in reference [27], peak III was identified
as 1,1,1-kestopentaose.
δ
2
(
(
1
(
4
. Conclusions
The present research indicated that a novel strategy had been developed to separate and purify
FOS from total FOSs. Firstly, the sample was structurally modified by acetylation. Then, the
acetylated target compounds were isolated by HSCCC with two-phase solvent system composed of
petroleum ether–n-butanol–methanol–water (3:2:1:4, v/v), and three compounds with high purity were
obtained in one step. Finally, the target compounds were obtained by reduction reaction whose